Elsevier

What if the most neglected conditions were our greatest source of hope? 🌍 Rare diseases affect more than 300 million people worldwide — but their impact goes far beyond those communities. Research into rare diseases has driven some of the biggest breakthroughs in healthcare, including: 🔹 Gene therapies that aim to restore sight 🔹 Whole genome sequencing, now used in epilepsy and autism care 🔹 Biomarkers that inform cancer treatment Innovation often starts where the need is greatest. By unlocking solutions for the few, researchers are transforming outcomes for millions. 📖 Read how rare disease research is shaping the future of healthcare: http://spkl.io/6046AOYuw

PharmaPendium AI: Unlock regulatory insight, faster. Regulatory data is vast and complex — finding the right insights quickly is a challenge for life sciences teams. PharmaPendium AI is a generative AI assistant that helps regulatory, clinical, and preclinical professionals locate and apply insights from FDA and EMA documents in seconds. Built on Elsevier’s trusted regulatory database, it uses natural language search and Retrieval-Augmented Generation (RAG) to deliver citation-backed answers that support confident decisions. 🔍 Ask complex regulatory questions in plain language 📄 Get fully cited, source-linked responses ⚡ Save up to 66% in search and review time 🌍 Developed with responsible AI principles 🔗 Learn more: http://spkl.io/6040AOIxa

48% of clinicians now use AI at work, nearly double compared to last year. But more rely on general tools like ChatGPT — not clinical-specific ones. And only 30% say they’ve had enough training to use AI effectively. Clinicians are ready. They’re waiting for institutions to catch up. See what 2,000+ doctors and nurses told us in Clinician of the Future 2025: http://spkl.io/6045AO0qT

We’re committed to fostering a thriving workplace where our people feel supported and empowered to do their best work. This new initiative builds on our ongoing efforts to promote well-being and balance across RELX.

Humans often work less hard in teams. Weaver ants do the opposite. 🐜 New research in Current Biology by Cell Press shows these ants become 'superefficient' when working together, pulling 103 times their body weight by forming chains, insights that could transform robotics and swarm design. Full story. 👇

Stuart Whayman, President of Corporate Markets at Elsevier, joins The Tech Leaders Podcast to discuss how AI is reshaping research and development, and why human creativity remains essential. Listen here. 👇

How does Scopus AI’s newest innovation, Deep Research, create reports that feel like they’re written just for you? Deep Research leverages agentic AI, with a reasoning engine designed to support complex research workflows. When you ask a question, it develops a detailed research plan and performs dozens of searches across the vast, curated literature in Scopus. Throughout the process, it reviews findings, refines its strategy, and adjusts course as new insights emerge, ensuring a thorough and thoughtful exploration of your topic. The result? A comprehensive, downloadable report that can save days of preliminary research, uncovering connections and surfacing new perspectives that help propel you toward your next discovery. Learn more: http://spkl.io/6044A30e6

Clinicians don’t want AI to replace them — they want it to support them. Most see AI as a tool to save time, ease admin and improve care — but only if they can trust it. That means transparency, quality data, and keeping clinical judgment in human hands. The message is clear: AI should assist, not decide. Read more in Clinician of the Future 2025: http://spkl.io/6040A3WLw

ScienceDirect AI: Built with researchers, for researchers. ScienceDirect AI brings together an integrated, intuitive suite of tools to help researchers find trusted insights faster and work more efficiently. Learn more: http://spkl.io/6049AMaJU #AI #ScienceDirectAI

How can scientific publishing adapt to rapid change while safeguarding research integrity? In a recent podcast, Laura Hassink, Managing Director of Elsevier Journals, discusses the evolving role of publishers, open access, and the technologies shaping trusted research. Read the RELX article based on the conversation. 👇